Where AI Adds Real Value in Clinical Development: 2025 Insights
AI is accelerating all phases of clinical development, including patient selection, protocol design, trial operations, and regulatory compliance35.
AI-driven tools are streamlining protocol design, enabling hyperadaptive and error-free protocols that can be updated in real time, significantly reducing trial timelines from years to weeks45.
Generative AI and SaaS solutions are transforming clinical trials into scalable, technology-first processes, empowering teams with self-service platforms that dynamically adapt to evolving needs4.
AI enhances patient recruitment by identifying eligible participants more efficiently and improving diversity in trial populations, as demonstrated by companies like Johnson & Johnson5.
AI applications in data management, such as automating data cleaning and analysis, are reducing manual workload and increasing accuracy for clinical researchers5.
AI is being used to support regulatory compliance, with machine learning-driven analyses to anticipate and prepare answers for regulator queries, and automate regulatory documentation, expediting approval processes5.
In March 2025, the launch of AI-powered assistants like Suvoda's Sofia exemplifies how AI is supporting study teams in clinical trial management, further streamlining operational tasks1.
The global market for AI in clinical trials is projected to grow at a CAGR of 12% by 2032, reflecting the widespread adoption and tangible impact of AI technologies in the life sciences sector1.
Sources:
1. https://www.globenewswire.com/news-release/2025/05/07/3076454/0/en/Global-AI-in-Clinical-Trials-Market-to-Show-Tremendous-Growth-at-a-CAGR-of-12-by-2032-DelveInsight.html
3. https://www.drugtargetreview.com/article/158593/early-evidence-and-emerging-trends-how-ai-is-shaping-drug-discovery-and-clinical-development/
4. https://globalforum.diaglobal.org/issue/january-2025/additional-predictions-for-2025/
5. https://medcitynews.com/2025/03/a-bright-future-for-ai-in-pharma/